2009 H1N1 vaccine safe and induces robust immune response in people with asthma

Results from a government-sponsored clinical trial of inactivated 2009 H1N1 influenza vaccine in people with asthma indicate that a single dose of vaccine was safe and induced a strong immune response predictive of protection. The findings also suggest that individuals over the age of 60 who have severe asthma may require a larger dose of vaccine.

Read the whole article on Science Daily

More from Science Daily